Lv61
2648 积分 2024-12-01 加入
Evaluating treatment responsiveness in rheumatoid arthritis through predictive metabolomic profiling: A systematic review of studies examining methotrexate, TNF, and IL-6 inhibitors as therapeutic interventions
14天前
已完结
New frontiers in rheumatoid arthritis therapy: From classic DMARDs to biologics and beyond
14天前
已完结
A review on the epidemiology of rheumatoid arthritis: An update and trends from current literature
15天前
已完结
Atypical Alzheimer's dementia: Addressing the subtypes, epidemiology, atypical presentations, diagnostic biomarkers, and treatment updates
16天前
已完结
Clinical development success rates for investigational drugs
1个月前
已完结
Zanubrutinib: First Approval
1个月前
已完结
Simultaneous development of zanubrutinib in the USA and China
1个月前
已完结
Compressed regulatory learning in emerging pharmaceutical markets
1个月前
已完结
Resource allocation patterns in regulatory review: A comparative analysis of FDA and NMPA
1个月前
已关闭
皖公网安备34019202002308
